Fibroblast growth factors (FGFs) play numerous regulatory functions in complex organisms, and their corresponding therapeutic potential is of growing interest to academics and industrial researchers alike. However, applications of these proteins are limited due to their low stability in vivo and in vitro. Here we tackle this problem using a generalizable computer-assisted protein engineering strategy to create a unique modified FGF2 with nine mutations displaying unprecedented stability and uncompromised biological function.
Introduction
The structurally related and highly conserved polypeptides from the family of FGFs are involved in a number of physiological processes in diverse animal species including humans.
There has been a considerable effort in investigating members of the FGF family for applications in pharmacy and bioengineering 1 . Specifically, human FGF2 serves as a pleiotropic regulator of proliferation, differentiation, migration, and survival in a variety of cell types and has been studied as a promising agent in treatment of cardiovascular diseases 2 , cancer 3 and mood disorders 4 . It has also been shown to have efficacy in ulcer, wound 5, 6 and epithelium healing 7 and is being routinely used as an essential component of cultivation media for human embryonic stem cells 8 .
The long-term maintenance of growth factors in the tissue or media is desirable for protein therapies and stem cell culturing, but is hindered by low thermal stability of the molecules and their limited half-life 1, 9, 10 . Stability of FGFs was shown to be enhanced by coadministration with heparin 11 , conjugation to heparin-mimicking polymers 12 , encapsulation in not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Results and discussion
Using our platform, we proposed 12 single point mutations (R31L, R31W, V52T, H59F, C78Y, N80G, L92Y, C96Y, S109E, R118W, T121K, and V125L) and 7 positions for randomization (E54, C78, R90, S94, C96, T121, and S152) to stabilize FGF2 by computationally searching for mutations that would minimize the Gibbs free energy of the native state combined with a back-to-consensus analysis ( Fig. 1 step I, Supplementary Figs. 1-2 ). Three out of twelve most stabilizing substitutions were identified by the phylogenetic approach 22 and nine mutations were predicted from energetics using FoldX 23 and Rosetta ddg monomer 24 (Supplementary Tables 1 and 2 ). Seven positions with the highest number of potentially stabilizing mutations as defined by the difference in their free energy (G) < -1 kcal.mol -1 were considered for randomization in order to look for further beneficial substitutions overlooked by the rational approach (Supplementary Table 2 ). Functionally relevant positions, namely those residues within heparin or receptor binding sites, were excluded from the designs to avoid mutations compromising activity. Initially, 12 computationally designed point mutants (FGF2-G1A) were constructed and tested leading to 7 stabilizing substitutions at 6 different positions with Tm between 0.9 and 3.7°C. Six selected not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Subsequently, 420 clones from 7 focused site-saturation mutagenesis libraries were screened for enhanced thermostability and retained biological activity (FGF2-G1B), revealing 14 beneficial substitutions at 5 randomized positions with Tm between 0.3 and 2.9°C. Guided by computational predictions, 5 substitutions from rational design were combined with 4 mutations from semi-rational design providing the third generation protein FGF2-G3 with Tm of 19°C.
For the purpose of in vitro mutagenesis ( Fig. 1 steps II and IV) , the gene encoding wildtype FGF2 was subcloned into vector pET28b with cleavable N-terminal His tag giving rise to the recombinant variant designated FGF2-G0 ( Supplementary Fig. 2 ). The numbering of mutations used herein corresponds to the original sequence of wild-type FGF2 ( Supplementary   Fig. 2c ). The genes of 12 rationally designed single-point mutants representing the first generation of engineered FGF2 (FGF2-G1A) were synthesized. Twelve mutants were produced in soluble form in Escherichia coli BL21(DE3) in quantities similar to that of FGF2-G0 (± 5% of the total soluble protein) and purified to homogeneity using affinity chromatography.
Biophysical characterization ( Fig. 1 step II) verified proper folding of all 12 mutants and improved Tm for 7 out of 12 constructed variants (Supplementary Table 3 ). Six beneficial mutations (R31L, V52T, H59F, L92Y, C96Y, and S109E) were re-combined in the cumulative mutant FGF2-G2 ( Fig. 1 step III) , which was obtained at a yield of 20 mg.L -1 . The experimental
Tm of properly folded FGF2-G2 (68.0 ± 0.2°C) was about 14.5°C higher than Tm of FGF2-G0
(53.5 ± 0.5°C). This value corresponds well with the theoretical sum of contributions of individual substitutions, suggesting strictly additive stabilizing effect of mutations in FGF2- Table 4) .
G2 (Supplementary
not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; In the next step, 7 computationally pre-selected positions in FGF2-G0 were randomized ( Fig. 1 step IV ) using fixed oligo technology, which reduced the screening effort needed to only 60 clones per library to obtain full coverage. Crude extracts of individual E. coli clones were prepared in microtiter plates and used to test simultaneously for biological activity and stability of FGF2 mutants in growth arrest assay with rat chondrosarcoma cells ( Supplementary   Fig. 3 ). Altogether, 33 new FGF2-G1B mutants were identified during the screening and successfully produced in E. coli to the levels similar to that of FGF2-G0. Thermal shift assays with purified proteins revealed 14 stabilizing amino acid substitutions in 5 out of 7 randomized positions (Supplementary Table 5 ). Mutations showing an improved thermostability of at least 1°C (E54D, S94I, C96N, and T121P) were computationally merged with existing mutations in FGF2-G2 (R31L, V52T, H59F, L92Y, C96Y, and S109E, while replacing C96Y by C96N) leading to the third generation variant FGF2-G3 ( Fig. 1 steps V and VI and Fig. 2a) .
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; Both FGF2-G2 and FGF2-G3 retained most of their original activity for 20 days of experiment, while FGF2-G0 lost half of its activity within initial 10 hours as determined by densitometric analysis of the corresponding Western blots (Supplementary Fig. 8 ). (f) FGF2-G2 and FGF2-G3 support proliferation of human embryonic stem cells better than the wild type. Columns show means, error bars represent standard error of the mean from three independent experiments. Student´s t-test, **p<0.01, *p<0.05.
Abbreviations: MRE, mean residual ellipticity; ctrl, control with no FGF2; h, hours; d, days.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; 8 Purified FGF2-G3, obtained with the yield of 11 mg.L -1 , was initially characterized in vitro using a wide spectrum of biophysical methods ( Fig. 1 Fig. 2c and Supplementary   Fig. 4 ). Fitting the data to a two-step unfolding mechanism suggested that gained stability was due to an increase in the Gibbs activation energy of the first unfolding step, which is in excellent agreement with our overall computational strategy of lowering the energy of the native state Biological assays confirmed the enhanced stability of engineered growth factors translated into their prolonged activity in vitro and in vivo ( Fig. 1 step VII) . Specifically, while the activity of FGF2-G0 in an ERK1/2 assay with human embryonic stem cells dropped to 50 % within initial 10 ± 2 hours of pre-incubation in conditioned medium at 37°C (Fig 2e and Supplementary Fig. 8 ), which is in good agreement with data obtained previously by different techniques 1, 25 , G2 and G3 mutants retained most of their activity for the full length of the study period (20 days) at the physiological temperature. In the second assay, the human embryonic stem cells were propagated in medium conditioned with each of the tested FGF2 variants with no additional supplementation, and the cell numbers and morphology were recorded for five consecutive passages ( Fig. 2f and Supplementary Fig. 9 ). While conditioned medium prepared with FGF2-G0 caused significant growth retardation, the cells incubated in the medium with either G2 or G3 mutant gave rise to monolayers, suggesting that repeated supplementation of the conditioned medium is not required with these proteins. Immunostaining for Oct-4 and not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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The biological activity of the stabilized variant was confirmed in vivo by injecting either FGF2-G0 or FGF2-G3, sorbed into a non-biodegradable hydrogel, into the shaved dorsal skin of telogenic C57BL/6 mice ( Supplementary Fig. 11 and 12 ). It is known that growth factors from FGF family have positive effect on hair growth and hair follicle stimulation. 26 We evaluated the degree of black pigmentation and hair growth photometrically by observing the skin color for 20 days. In 2 weeks, both FGF2 induced black coloration in the shaved skin with remarkably stronger hair growth induction in group injected with thermostable FGF2 (Fig. 3a , Supplementary Fig. 12 ). The control group with empty hydrogel showed significant retardation in transition from telogen to anagen stage as seen on skin coloration. The hair length of plucked hair in the proximity of injected site confirmed that thermostable FGF2 stimulated growth of hairs more significantly comparing to FGF2-G0 and the control group with no FGF2 applied (Fig. 3b) . No toxic effects of recombinant proteins were observed.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; In summary, we constructed a hyperstable nine-point mutant FGF2-G3 using a hybrid computational engineering strategy and focused directed evolution by constructing only 14 mutants and testing only 420 clones. The FGF2-G3 shows a 19°C increase in melting temperature and greater than 48-fold improved half-life at 37°C, representing the most thermostable FGF2 with fully preserved biological activity known to date. Our hyperstable FGF2 supports the undifferentiated growth of human embryonic stem cells, induces the appropriate downstream signaling cascade, and stimulates hair growth in mouse model, demonstrating that its biological activity towards highly sensitive cells remained unmodified.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; We anticipate this construct will be directly applicable to stem cell culturing 13 , and will find broad use in clinical medicine 1, 12 , cosmetics 26 , and dietary supplements. The successful demonstration of rapid protein stabilization highlights the power of our rational protein engineering strategy and should encourage wider use of the described workflow for stabilizing growth factors and other protein therapeutics that are currently being tested for use in cancer treatment, regenerative medicine, or a number of metabolism-associated disorders 1 .
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Materials and methods

Prediction of stabilizing effect of single-point mutations by evolution-based approach
Multiple sequence alignment and evolutionary conservation analysis. The FGF2 isoform 3 protein sequence (UniProt identifier: P09038-2) was used as a query for PSI- using the empirical Bayesian method 34 and WAG model of evolution 35 . The evolutionary rates were then converted to the ConSurf conservation scale 36 .
Selection of individual mutations. The multiple sequence alignment comprising 238
FGF2 protein sequences was used as an input for back-to-consensus analysis using the simple consensus approach. The analysis was performed using the consensus cut-off of 0.5, meaning that a given residue must be present at a given position in at least 50% of all analysed sequences to be assigned as the consensus residue. Stability effects of all possible single-point mutations in FGF2 protein were estimated by free energy calculations (see following section for the calculation details). Only mutations with average Gibbs free energy (ΔΔG) ≤ 1 kcal.mol -1 predicted by both FoldX 22 and Rosetta 23 were considered as hot-spots for FGF2 stabilization.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; Functionally important sites of FGF2 were excluded as potentially deleterious mutations for biological function. Results of the back-to-consensus analysis are summarized in Supplementary Table S1 . The numbering corresponds to the sequence of wild-type human FGF2 ( Supplementary Fig. 2c ). Ten mutations were excluded based on the high value of predicted ΔΔG or its high uncertainty of the prediction, and three mutations were discarded from the design due to their location at functionally important positions for the heparin binding. not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; Prediction of stability effects by Rosetta. Repaired structures were minimized by the minimize_with_cst module of Rosetta 23 with both backbone and side-chains optimization enabled (--sc_min_only false), distance for full atom pair potential set to 9 Å (--fa_max_dis 9.0), standard weights for the score function and a constraint weight of 1 (--constraint_weight
1.0).
Output from the minimization was used to constraint Cα atoms with harmonic function within 0.5 Å distance from the initial position in the crystal structure. Protocol 16 incorporating backbone flexibility within the ddg_monomer module of Rosetta was applied according to
Kellogg and co-worker 23 . The soft-repulsive design energy function (--soft_rep_design weights) was used for repacking side-chains (--sc_min_only false). Optimization was performed on each whole protein without distance restriction (--local_opt_only false). The previously created constraint file was used during backbone minimization (--min_cst true).
Three rounds of optimization with increasing weight on the repulsive term (--ramp_repulsive
true) were applied. The minimum energies from 20 iterations were used as the final parameters describing the stability effects of single -point mutations.
Selection of individual mutations. Mutations predicted as stabilizing by either FoldX or
Rosetta tool (ΔΔG < -1.0 kcal.mol -1 ) and not significantly constrained during evolution (Consurf conservation score < 8) were selected for further analysis. In this way, the potentially stabilizing mutations with only a limited influence on functional regions, e.g., heparin binding residues, were identified. Residues forming the FGF2/FGFR1 interface (PDB-ID code 1CVS) and FGF2/FGFR2 interface (PDB-ID code 1EV2) were identified using the PISA server 38 and were discarded from the selection. Nine single-point substitutions were selected for experimental construction and characterization: R31W, R31L, H59F, C78Y, L92Y, C96Y, R118W, T121K and V125L (Supplementary Table 2 ). Interestingly, the L92Y mutation was identified also previously by evolutionary-based approach. The numbering of these mutants corresponds to the sequence of wild-type human FGF2 ( Supplementary Fig. 2c ).
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Every protein position was saturated by all twenty proteinogenic amino acids and number of stabilizing mutations (ΔΔG < -1.0 kcal.mol -1 ) was identified for individual positions. Positions with conservations score > 7 or situated on the functional regions were discarded. Seven positions with the highest number (> 3) of stabilizing mutations (E54, C78, R90, S94, C96, T121, and S152) were selected for saturation mutagenesis (Supplementary Table 2 ). Positions 31 and 59 were discarded from selection because significant improvement in thermostability (ΔTm=4°C and 3°C, respectively) was verified experimentally for the mutations R31L and H59F (Supplementary Table 3 ). Therefore, the probability of further considerable improvement was negligible.
Construction, production and characterization of single point FGF2-G1A variants
Twelve FGF2-G1A variants R31W, R31L, V52T, H59F, C78Y, N80G, L92Y, C96Y, S109E, R118W, T121K and V125L were commercially synthesized (GeneArt/Life 
Cells in suspension were disrupted by sonication using ultrasonic processor Hielscher UP200S (Teltow, Germany) with 0.3 s pulses and 85 % amplitude. Cell lysate was centrifuged for 1 h at 21,000 g at 4°C. FGF2 variants were purified from crude extracts using single step nickel affinity chromatography. Crude extracts were applied to a 
Peltier thermostat. Data were collected from 200 to 260 nm, at 100 nm.min -1 , 1 s response time and 2 nm bandwidth using a 0.1 cm-quartz cuvette. Each spectrum is the average of five individual scans and is corrected for absorbance caused by the buffer. Collected CD data were expressed in terms of the mean residue ellipticity. Thermal unfolding was followed by monitoring the ellipticity at 232 nm over the temperature range from 20 to 80°C at a heating rate 1°C.min -1 . Recorded thermal denaturation curves of FGF2 variants were normalized to represent signal changes between approximately 0 and 1 and fitted to sigmoidal curves. The melting temperatures were evaluated from the collected data as a midpoint of the normalized thermal transition.
Free energy calculations, construction and thermostability analysis of FGF2-G2 mutant
All mutations improving the melting temperature by at least 0.5°C were selected for in silico analysis using Rosetta ddg monomer application 23 as described earlier. In the case of two stabilizing mutations on the same position, the mutation with the larger effect was chosen.
Selected mutations were then tested for potential antagonistic effect. The additivity of stabilizing mutations was evaluated by predicting the stability of variants with all pairs of stabilizing single-point mutations (Supplementary Table 4) . Mutation pairs for which the respective double-point mutants showed lower stability in the comparison with the sum of both single-point mutants taken separately would be considered as antagonistic. However, none of the double-point mutants had the difference > 1 kcal.mol -1 suggesting the absence of any significant antagonistic effects among the selected mutations. All mutations improving Tm by at least 0.5°C (R31L, V52T, H59F, L92Y, C96Y and S109E) were combined into 6-point mutant designated FGF2-G2. The gene of multiple-point mutant was commercially synthesized (GeneArt/Life Technologies, Germany), subcloned in the NdeI and XhoI sites of pET28b-Hisnot peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Construction and screening of focused site-saturation mutagenesis libraries
Altogether 7 focused site-saturation mutagenesis libraries were constructed commercially using "Fixed Oligo" technology of GeneArt (Life Technologies, USA). The pET28b-His-thrombin::fgf2 was used as a template for randomization. Plasmid DNA was The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; 3 mM, respectively. Plates were incubated overnight at 20°C with shaking (180 rpm). After 22 hrs, the plates were centrifuged for 20 min (3000 g, 4°C) using Sigma 6-16K (Sigma Laborzentrifugen, Germany). Supernatant was drained using JP recirculating water aspirator (VELP Scientifica, Italy). Whole microtiter plates with cell pellets were frozen at -70°C. Then, plates were incubated for 20 min at room temperature and 100 µl of lysis buffer (20 mM sodium phosphate buffer, 150 mM NaCl, pH 7.0) was added into the each well. Plates were incubated for 20 min at 30°C with shaking (200 rpm). Cell debris was removed from resulting cell lysates.
Concentration of total soluble protein in crude extract in one well with negative control, one well with positive control, one well with background control and in 6 randomly selected wells with new FGF2-G1B mutants was determined for each plate containing one of the libraries using Bradford reagent (Sigma Aldrich, USA). Samples of crude extracts from the same wells were loaded on SDS polyacrylamide gels. The gels were analysed using GS-800 Calibrated Densitometer (Bio-Rad, USA) and the content of FGF2 in the total soluble protein in each sample was determined. The concentration of FGF2 in crude extracts was calculated based on the obtained data. The plates with crude extracts were stored at -70°C for further use. variant (2.5 mg.ml -1 ) and the elution buffer (100 mM HEPES, 500 mM imidazole and 500 mM NaCl, pH 7.5). The assay was performed using StepOnePlus Real-Time PCR System (Applied Biosystems/Thermo Fisher Scientific, USA) with starting temperature of 25°C (2 min initial equilibration) and ramping up in increments of 1°C to a final temperature of 95°C. The Tm values were determined from obtained data using Protein Thermal Shift software (Applied Biosystems/Thermo Fisher Scientific, USA; Supplementary Table 5) .
Screening of biological activity of FGF2-G1B variants using rat chondrosarcoma growth-arrest assay. Rat chondrosarcoma (RCS) cells is an immortalized
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Free energy calculations, construction and purification of FGF2-G3 mutant
All mutations from screening improving the melting temperature by at least 1°C (E54D, S94I, C96N, and T121P) were selected for in silico analysis using Rosetta ddg monomer application 23 coli BL21(DE3) cells as described before.
Characterization of biophysical properties of FGF2-G3 and its comparison with FGF2-
G0 and FGF-G2 variants.
DSC was used to characterize protein thermal stability of protein purified by affinity chromatography. DSC data collection was performed over a temperature range of 20°C-100°C.
Proper folding of mutant was verified by CD spectroscopy as described earlier.
Circular dichroism spectroscopy. The structural integrity of FGF2-G0, FGF2-G2 and FGF2-G3 proteins was followed by monitoring the ellipticity over the wavelength range of 200 not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; to 260 nm at the temperature 37, 50, 65 and 70°C for 24 h. Data were recorded in 2 minute intervals with 1 nm bandwidth using a 0.1 cm quartz cuvette containing the protein. Recorded denaturation curves (either single exponential, double exponential or exponential linear combination function) of tested FGF2 variants were globally fitted to exponential decay curves using OriginPro8 software (OriginLab, USA). Half-life of FGF2 secondary structure (t1/2 defined as a time required to reduce the initial value of ellipticity, as a measure of protein secondary structure, to ½ of the original value) was evaluated from the collected data as a decay constant (τ) using the equation:
where λ is exponential decay constant. The t1/2 was evaluated from the data collected at 227 nm, where all spectra showed the ellipticity maxima ( Supplementary Fig. 4 ). Fluorescence spectroscopy. Local conformational changes during thermal unfolding of FGF2 variants were followed by monitoring fluorescence emission spectra using FluoroMax spectrofluorometer (Horiba, Japan). The sample in quartz cuvette with a magnetic stirrer inside was placed into a temperature-controlled holder, and fluorescence spectra excited at 295 nm were recorded in 1 minute intervals from 310 to 410 nm with 1 nm bandwith and 0.1 s integration time from 30 to 90 °C. The actual temperature in the cell was monitored using thermocouple controlled by Labview software (National Instruments, USA). The spectrum of not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; the buffer recorded at 30 °C was used as a blank and subsequently subtracted from the sample data. Unfolding was followed at the emission maximum (347 nm) of the first scan. The concentration of all the samples was approx. 0.1 mg.ml -1 . were the same at the optimal point. Regarding the parameters, linear coefficients were allocated separately to each data set. The models with the minimum number of intermediates were selected based on the quality of fit measured by normalized residuals and visual inspection.
Differential scanning fluorescence (DSF)
Although the datasets of the wild type and the G2 mutant were fitted reasonably well with just a three-step irreversible model, the G3 model had to include one additional reversible pretransitional step to fit all the data sets perfectly, mainly due to the DSC data and ratiometric not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; data from DSF. Nonetheless, the effect of this step is much less pronounced than the subsequent irreversible steps of unfolding in all the datasets. The estimated values of the main parameters of the unfolding mechanism are given in Supplementary Table 6. pH profile. Britton-Robinson buffers of different pHs (5, 6, 7, 7.5, 8, 9, 10 and 11) were used for determination of pH stability profile for the FGF2 variants. 5 µL sample aliquot was mixed with 95 µL of BR buffer of appropriate pH, thoroughly vortexed and incubated for 3 h at 4 °C. Next standard grade capillary was filled with a mixture by capillary forces and put into the Prometheus NT.48. Samples were scanned from 30 to 90 °C at 1°C.min -1 scan rate.
Characterization of biological properties of FGF2-G3 and its comparison with G0 and
G2 variants
The authors herein declare that all following experiments conducted on animals or human cells were carried out in accordance with relevant guidelines and regulations. All The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; and Western blotted for phosphorylated ERK1/2. Two representative blots per each protein variant were analysed using ImageJ 1.50b (National Institutes of Health, USA) and band densities were plotted as a function of pre-incubation time (Supplementary Fig. 8 ). Data points were analysed using single exponential decay equation:
where A/A0 is the relative density at time t, τ is the time constant, and c is steady state level of density offset, with help of OriginPro8 software (OriginLab, USA) and the half-life (i.e. the time required for the loss of one-half of the initial activity) was determined for FGF2-G0 protein variant.
Western blotting. Cells were lysed with 2x Laemmli buffer and the samples were boiled at 98°C for 10 minutes. Proteins were separated by SDS-PAGE and electrotransferred onto Immobilon®-P transfer membrane (Merck Millipore, Germany). Membranes were then blocked in 5% milk in TBS buffer and incubated with primary rabbit polyclonal antibody P-44/42 MAPK (Cell Signaling Technologies, USA) at 4°C overnight. The primary antibodies included rabbit polyclonal anti-pERK1/2 and rabbit polyclonal anti-ERK1/2 (both Cell Signaling Technology, USA). Next day, the membranes were incubated with donkey antirabbit antibodies conjugated with horse raddish peroxidase (Santa Cruz Biotechnology, USA), and the protein bands were visualized using chemiluminiscence detection reagent ImmobilonTM Western (Merck Millipore, Germany) on photographic paper (Agfa-Gevaert, Belgium). After stripping, the membrane was re-probed with rabbit polyclonal antibody p44/42 MAPK (Erk1/2) (Cell Signaling Technology, USA) against total signaling proteins. not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; Cell cultures. The hESC employed in this study were derived from blastocyst-stage embryos obtained with informed consent of donors. A well characterized human ESC line (Adewumi, 2007) CCTL14 (Centre of Cell Therapy Line) in passages 65 -75 was used. The hESC were maintained under feeder-free conditions using MatrigelTM hESC-qualified Matrix (BD Biosciences). Culture medium required for propagation of hESC grown on Matrigel was medium conditioned by mitotically inactivated mouse embryonic fibroblasts (mEF). For preparation of standard conditioned medium (CM), the complete hESC medium containing 4 ng.ml -1 FGF2 is usually conditioned by mitotically inactivated mEF for 5-7 days and then supplemented by 10 ng.ml -1 of FGF2 to restore growth factor concentration due to its degradation. In our experiments, to test the long-term thermostability of FGF2, the CM was prepared out of medium containing 10 ng.ml -1 of FGF2 with no supplementation afterwards.
Proliferation assays. The hESC were plated into 24-well plates and propagated in presence of each of the tested FGF2 for five passages and counted every three days after plating using Burker chamber. Alternatively, cells were plated into 94-well plates and cultured in the presence of various FGF2 for 6 days. Cells were then fixed in 4% paraformaldehyde (20 min, RT), stained with 0.1% crystal violet (60 min, RT), and destained with 33% acetic acid (20 min with shaking). The absorbance of the supernatant was then measured at 570 nm using plate reader ( Supplementary Fig. 9 ).
Immunocytochemistry. The hESC were fixed with 4% paraformaldehyde (20 min, RT), permeabilized with 0.1% Triton-X100 in PBS (20 min, RT), and incubated with primary antibodies at 4°C overnight. Primary antibodies included goat polyclonal anti-Oct4 (Santa Cruz Biotechnology, USA) and rabbit monoclonal anti-Nanog (Cell Signaling technology, USA).
Next day, incubations with secondary antibodies conjugated to AlexaFluor488 or AlexaFluor594 (Thermo Fisher Scientific, USA) were carried out at RT for 1 h. Coverslips not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Preparation of hydrogel. Macroporous poly(2-hydroxyethyl methacrylate) (PHEMA) microspheres of narrow particle size distribution were prepared by multi-step swelling polymerization. 43 Briefly, the method is based on 0.7 µm monodisperse polystyrene seeds which are swollen with activating agent (dibutyl phthalate), monomers (2-(methacryloyl)oxyethyl acetate, 2-[(methoxycarbonyl)methoxy]ethyl methacrylate, ethylene dimethacrylate), and porogen (cyclohexyl acetate). After benzoyl peroxide-initiated and (hydroxypropyl)methyl cellulose-stabilized polymerization, hydrolysis, and washing, the resulting PHEMA microspheres were 3 µm in diameter, with a narrow size distribution ( Supplementary Fig. 11 ) and contained 0.5 mmol COOH/g.
In vivo experiment. Animals used in the study of hair promoting activity, 7 weeks old female C57BL/6 mice, were obtained from Laboratory Animal Breeding and Experimental Facility (Masaryk University, Brno, Czech Republic) and maintained on a standard laboratory diet and water as libitum. 17 animals in 3 randomized groups (n=5 or 6) were shaved using depilatory cream (Veet, USA) at 7 weeks of age, at which all hair follicles were synchronized in the quiescence telogen. 44 FGF2, both FGF2-G0 and thermostable variant FGF2-G3 (5 µg per mouse) were dissolved in 0,1% human serum albumin and sorbed into the hydrogel by continuous stirring for 2 hours at RT. The resulted suspension was applied topically on dorsal skin of C57BL/6 mice with subcutaneous injection. Empty hydrogel with no FGF2 was used as a control. Visible hair growth was recorded at days 1, 7, 13, 16 and 20 ( Supplementary Fig.   12 ).
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/100636 doi: bioRxiv preprint first posted online Jan. 15, 2017; Hair length determination. To examine the effect of FGF2 in hydrogel on hair length, hairs on the proximity of injected site were plucked randomly by forceps at day 21 post application. The average length of the 20 plucked hairs per mouse was measured manually with a micrometer under a stereoscopic microscope and expressed in millimeters.
